Low-Flow, Low-Gradient Aortic Stenosis

1

Review clinical trials related to Low-Flow, Low-Gradient Aortic Stenosis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Transcatheter Aortic Valve Replacement in Severe Low Flow, Low Gradient Aortic Stenosis

LOW-TAVR is a real-world, retrospective and prospective, multicenter Italian registry aimed at evaluating the characteristics and clinical outcomes of patients with severe low flow, low gradient aortic stenosis undergoing transcatheter aortic valve replacement (TAVR) and, in particular: * risk factors * gender differences * comorbidities * pharmacological treatment * TAVR procedural characteristics * periprocedural and in-hospital complications * clinical outcome at 30-day, 1-year, 2-year and 5-year follow-up

Participants needed: 1,350
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University of SalernoUpdated: Apr 7, 2026Locations: 1Duration: 5 Years
Eligibility criteria

LFLG-AS diagnosis according to current European Society of Cardiology guidelines [+2]

LFLG-AS pseudo-severe or non-confirmed severe aortic stenosis [+1]